X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-243.80%
↑ 47% vs avg
Percentile
P30
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-456.88%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -243.80% | +77.4% |
| 2024 | -1078.45% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | +100.0% |
| 2020 | -1935.50% | - |
| 2019 | 0.00% | +100.0% |
| 2018 | -1311.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |